AlgoTx
www.algotx.comAlgoTx develops novel solutions for complex pain. Our lead program, ATX01, targets highly prevalent Chemotherapy-Induced Peripheral Neuropathy and the orphan disease erythromelalgia.
Read more
AlgoTx develops novel solutions for complex pain. Our lead program, ATX01, targets highly prevalent Chemotherapy-Induced Peripheral Neuropathy and the orphan disease erythromelalgia.
Read more
Country
City (Headquarters)
Suresnes
Industry
Employees
1-10
Founded
2018
Social
Employees statistics
View all employeesPotential Decision Makers
Board Member
Email ****** @****.comPhone (***) ****-****Chief Financial Officer
Email ****** @****.comPhone (***) ****-****President and Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Scientific Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(6)
Reach decision makers at AlgoTx
Free credits every month!
AlgoTx FAQ
Suresnes, France
Biotechnology Research
